Evidence map›Paper›PMID 20590563›Full record

ReviewBritish journal of pharmacology2010

Endocannabinoid signalling: has it got rhythm?

Linda K Vaughn, Gerene Denning, Kara L Stuhr, Harriet de Wit, Matthew N Hill, Cecilia J Hillard

Open access · bronzeAbstract readReview
In one paragraph

Review in British journal of pharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 1 synthesis or guideline pooled it, 181 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Exercise-induced endocannabinoid signaling is modulated by intensity.European journal of applied physiology · 2013
    Trial
  5. Review
  6. The interplay of circadian rhythms and cancer pain: a narrative review.Journal of anesthesia, analgesia and critical care · 2026
    Review
  7. Overlapping pathways of migraine and the endocannabinoid system: Potential therapeutic targets.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  8. Article
  9. Interactions between cannabis use and chronic pain on sleep architecture: Findings from in-home EEG recordings.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  10. Endocannabinoid system and mood responses to acute aerobic exercise in adult cancer patients versus healthy controls: a pilot study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Understanding the Role of Endocannabinoids in Posttraumatic Stress Disorder.International journal of molecular sciences · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Longitudinal course of endocannabinoids andPsychological medicine · 2023
    Article
  19. Review
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Linda K VaughnDepartment of Biomedical Sciences, Marquette University, Milwaukee, WI, USA.
Gerene Denning
Kara L Stuhr
Harriet de Wit
Matthew N Hill
Cecilia J Hillard
Medical College of Wisconsin · USMarquette University · USRockefeller University · USUniversity of Chicago · USUniversity of Iowa · US

Funding

BIOCHEMISTRY OF ANANDAMIDE, AN ENDOGENOUS CANNABINOIDR01DA009155 · NIDA · MEDICAL COLLEGE OF WISCONSIN · PI HILLARD, CECILIA J · 1996 to 2011
$3.4M
REINSTATEMENT OF DRUG TAKINGR01DA009133 · NIDA · UNIVERSITY OF CHICAGO · PI DE WIT, HARRIET · 1996 to 2009
$2.5M
CIHRNCRR NIH HHS M01RR000555NIDA NIH HHS DA09133NIDA NIH HHS DA09155NIDA NIH HHS R01 DA009133NIDA NIH HHS R01 DA009155
6 · The paper itself

Abstract

Endogenous cannabinoid signalling is widespread throughout the body, and considerable evidence supports its modulatory role in many fundamental physiological processes. The daily and seasonal cycles of the relationship of the earth and sun profoundly affect the terrestrial environment. Terrestrial species have adapted to these cycles in many ways, most well studied are circadian rhythms and hibernation. The purpose of this review was to examine literature support for three hypotheses: (i) endocannabinoid signalling exhibits brain region-specific circadian rhythms; (ii) endocannabinoid signalling modulates the rhythm of circadian processes in mammals; and (iii) changes in endocannabinoid signalling contribute to the state of hibernation. The results of two novel studies are presented. First, we report the results of a study of healthy humans demonstrating that plasma concentrations of the endocannabinoid, N-arachidonylethanolamine (anandamide), exhibit a circadian rhythm. Concentrations of anandamide are threefold higher at wakening than immediately before sleep, a relationship that is dysregulated by sleep deprivation. Second, we investigated differences in endocannabinoids and congeners in plasma from Marmota monax obtained in the summer and during the torpor state of hibernation. We report that 2-arachidonoylglycerol is below detection in M. monax plasma and that concentrations of anandamide are not different. However, plasma concentrations of the anorexigenic lipid oleoylethanolamide were significantly lower in hibernation, while the concentrations of palmitoylethanolamide and 2-oleoylglycerol were significantly greater in hibernation. We conclude that available data support a bidirectional relationship between endocannabinoid signalling and circadian processes, and investigation of the contribution of endocannabinoid signalling to the dramatic physiological changes that occur during hibernation is warranted.

Indexed as

EndocannabinoidsAnimalsBrainCannabinoid Receptor ModulatorsCircadian RhythmHibernationHumansPhysiological PhenomenaSignal TransductionCannabinoid Receptor ModulatorsEndocannabinoids

Identifiers

PMID20590563
PMCPMC2931554
OpenAlexW1533581117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.